everads-therapy.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.everads-therapy.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home
Description	Send us a message and we’ll get back to you Everads is an emerging startup with novel delivery technology to treat retinal diseases via suprachoroidal administration and is developing an early-stage pipeline that leverages our technology. Our technology enables delivery of therapy to the
Keywords	N/A

Server Information

WebSite	everads-therapy.com
Host IP	185.230.63.107
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

everads-therapy.com Valuation

US$1,005

Last updated: 2023-05-20 04:23:09

everads-therapy.com has Semrush global rank of 0. everads-therapy.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. everads-therapy.com receives approximately 116 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, everads-therapy.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,005
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$27
Yearly Ads Revenue	US$334
Daily Unique Visitors	7
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
everads-therapy.com.	A	3600	IP: 185.230.63.107
everads-therapy.com.	A	3600	IP: 185.230.63.171
everads-therapy.com.	A	3600	IP: 185.230.63.186
everads-therapy.com.	NS	86400	NS Record: ns7.wixdns.net.
everads-therapy.com.	NS	86400	NS Record: ns6.wixdns.net.
everads-therapy.com.	MX	3600	MX Record: 1 everadstherapy-com01i.mail.protection.outlook.com.
everads-therapy.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
everads-therapy.com.	TXT	3600	TXT Record: MS=ms17881177

HtmlToTextCheckTime:2023-05-20 04:23:09

top of page E VERADS T HERAPY Home Team Our Technology Pipeline Publications Partnerships News OPTIMAL TREATMENT OF RETINAL DISEASE LEVERAGING NOVEL DELIVERY TECHNOLOGY Start Here Everads: more effective, durable treatment for retinal diseases. Our technology facilitates targeted, rapid delivery of therapy via the emerging suprachoroidal delivery route. Leveraging our technology, we are developing treatments to improve efficacy and reduce treatment burden, and also partnering with leading pharmaceutical and biotech companies to enable delivery of novel therapies using our technology. About Our Technology About Our Pipeline About Us start about About Everads Everads is an emerging startup with novel delivery technology to treat retinal diseases via suprachoroidal administration and is developing an early-stage pipeline that leverages our technology. Our technology enables delivery of therapy to the choroid and retina via the suprachoroidal space (SCS)…. More About Us Our Team NEWS HOME

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 07 Jan 2023 08:52:54 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.everads-therapy.com/
strict-transport-security: max-age=3600
x-wix-request-id: 1673081574.7812181047071424031
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=84
X-Seen-By: yKskFaTI/RmB0yGOaMOo6Q==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVg2DAeNe59gMKXXCgDpped9,m0j2EEknGIVUW/liY8BLLlXQtHW9kaoX9Rp39hufIvnJftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRalpPUazX8789D51RbGuVaTjU+mLv2U097u+98tbWjq51yONITQGrhuTYMLy55mKMJ+Q==,2UNV7KOq4oGjA5+PKsX47FK1FiZH5oKQPGEyHGuLowi8ZDY613cHYLbuhNMgAom1,7npGRUZHWOtWoP0Si3wDp3pk+fOCkUHYAkRreQULO2E=,xTu8fpDe3EKPsMR1jrheEPOlZo2AkD/zX00PWnN8WDY=,updaSF0YDozocDRTgMoSR/ExKe87ccLRgbg1Y/jzLFu8yFLE4ynvVTrFTmriFoksWIHlCalF7YnfvOr2cMPpyw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 07 Jan 2023 08:52:55 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1673081574.9103110630119064
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMe/pJAowCp9L91E5yWR10DQ,qquldgcFrj2n046g4RNSVMxfheUO4XmnqrwYf15pULU=,2d58ifebGbosy5xc+FRalriY+u0FZF8dssev0L3sCjyMq3YiTD4BUlp1GgYyTXSyxmHv8JmZfQswK4rISLAEpMtN3zbDnLPMxx7ZJaQ55rA=,2UNV7KOq4oGjA5+PKsX47NTaFvZEsXIsLVjEfrvlXStWd3xniMsr1HjrszKGvMzr,7npGRUZHWOtWoP0Si3wDp51+9XPl5dhGBnFdCJ2z9R8=,updaSF0YDozocDRTgMoSRw5MNXpfFa2qAltYFQk0CDurQQq8/UePryzkiBvz4f7cvGQ2Otd3B2C27oTTIAKJtQ==,xTu8fpDe3EKPsMR1jrheEDeruMGxWGUXAhRbSxAalJ8=,LoUK8/saGAmOxZWtpubo2gJGZ5aJ883Bogv1631MLoA4dIK/ne1g8QDXYfsfYp+tjf5V6HghY6Hdha6cODindw==,xTu8fpDe3EKPsMR1jrheEKHvXPS/Drb1EatLggYW5HM=,xTu8fpDe3EKPsMR1jrheECjNmcMCWeSPkecZF34dNOk=,/a5ccLSK1HEmwPNg/x6Oui9EM9/1qzDyzYb6V1igQ87Dv2RCo0K2tdwN9+OOAGNpsGVPGecZAyLdF4FK6scFMQ==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3_g; Max-Age=20; Expires=Sat, 07 Jan 2023 08:53:15 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

everads-therapy.com valuation and analysis